Oddrun Elise Olsen

Most-cited papers

1. Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

   Oddrun Elise Olsen, K. F. Wader, H. Hella, A. Mylin +5 more

   2015Cell Communication and Signaling147 citations Open access

   Semantic Scholar

   Save

2. TGF-β contamination of purified recombinant GDF15

   Oddrun Elise Olsen, Anette Skjærvik, B. Størdal, A. Sundan +1 more

   2017PLoS ONE78 citations Open access

   Semantic Scholar

   Save

3. Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

   M. Westhrin, S. Moen, T. Holien, A. Mylin +7 more

   2015Haematologica61 citations Open access

   Semantic Scholar

   Save

4. Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin

   Oddrun Elise Olsen, K. F. Wader, K. Misund, T. K. Våtsveen +9 more

   2014Blood Cancer Journal54 citations Open access

   Semantic Scholar

   Save

5. Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors

   Oddrun Elise Olsen, H. Hella, Samah Elsaadi, C. Jacobi +2 more

   2020Biomolecules51 citations Open access

   Semantic Scholar

   Save

6. BMPR2 inhibits activin and BMP signaling via wild-type ALK2

   Oddrun Elise Olsen, Meenu Sankar, Samah Elsaadi, H. Hella +6 more

   2018Journal of Cell Science50 citations Open access

   Semantic Scholar

   Save

7. Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate

   T. Holien, Oddrun Elise Olsen, K. Misund, H. Hella +3 more

   2013European Journal of Haematology39 citations

   Semantic Scholar

   Save

8. MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

   T. Holien, K. Misund, Oddrun Elise Olsen, K. Baranowska +4 more

   2015OncoTarget21 citations Open access

   Semantic Scholar

   Save

9. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells

   Ingrid Quist-Løkken, Clara Andersson-Rusch, M. Kastnes, J. Kolos +7 more

   2023Cell Communication and Signaling14 citations Open access

   Semantic Scholar

   Save

10. High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells

    Clara Andersson-Rusch, B. Liu, Ingrid Quist-Løkken, P. Upton +7 more

    2023Scientific Reports8 citations Open access

    Semantic Scholar

    Save

11. RNA-Integrity and 8-Isoprostane Levels Are Stable in Prostate Tissue Samples Upon Long-Term Storage at −80°C

    Sandra Amalie Dybos, Å. W. Brustad, T. Rolfseng, Solveig Kvam +3 more

    2020Biopreservation and Biobanking4 citations Open access

    Semantic Scholar

    Save

12. Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy

    T. Holien, K. Misund, Oddrun Elise Olsen, K. Baranowska +4 more

    2018OncoTarget1 citations Open access

    Semantic Scholar

    Save

13. BMPR2 inhibits activin- and BMP-signaling via wild type ALK2

    Oddrun Elise Olsen, Meenu Sankar, Samah Elsaadi, H. Hella +5 more

    2017bioRxiv1 citations Open access

    Semantic Scholar

    Save

14. The role of BMP receptor ALK2 in myeloma cells

    Oddrun Elise Olsen

    20170 citations

    Semantic Scholar

    Save

15. Abstract 2351: MYC gene copy number determine MYC expression and sensitivity to a MYC-inhibitor in multiple myeloma cells

    T. Holien, K. Misund, Glenn Buene, Oddrun Elise Olsen +3 more

    20140 citations

    Semantic Scholar

    Save

16. GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels are Associated with Multiple Myeloma Bone Disease

    Marita Westhrin, S. Moen, T. Holien, Oddrun Elise Olsen +5 more

    20140 citations

    Semantic Scholar

    Save

17. The role of bone morphogenetic protein-9 in multiple myeloma

    Oddrun Elise Olsen

    20120 citations

    Semantic Scholar

    Save